DDO-2213, CAS [[2378768-36-4]]

Produktübersicht

• Artikelname: DDO-2213, CAS [[2378768-36-4]]
• Artikelnummer: MCE-HY-153331
• Hersteller Artikelnummer: HY-153331
• Alternativnummer: MCE-HY-153331-5MG,MCE-HY-153331-10MG,MCE-HY-153331-100MG,MCE-HY-153331-25MG,MCE-HY-153331-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DDO-2213 is an orally active and potent WDR5-MLL1 inhibitor, with an IC50 of 29 nM and a Kd value of 72.9 nM for the WDR5 protein. DDO-2213 selectively inhibits MLL (mixed lineage leukemia) histone methyltransferase activity and the proliferation of MLL translocation-harboring cells. DDO-2213 can be used for MLL fusion leukemia research[1].

Produkteigenschaften

• Molekulargewicht: 483.97
• Reinheit: 98.84
• CAS Nummer: [2378768-36-4]
• Formel: C24H27ClFN7O
• Target-Kategorie: WDR5

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound